| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
2 companies
Corbin Capital Partners, L.P. last filed a Form 4 in October 2023 for WHLR. The filings on record cover 2 companies.
At the last filing, the largest reported position was 264,523 shares of WHLR. The WHLR filings lean toward selling, a net 254,961 shares.
Corbin Capital Partners, L.P. has 2 Form 4 filings on record from July 2023 to October 2023, across 2 companies: Wheeler Real Estate Investment Trust (WHLR), 2023; Tevogen Bio (TVGN), 2023.
The 3 reported transactions were 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $25.0M.
The largest open-market sale was 2,320,000 shares of TVGN at an average $10.68 on July 17, 2023, about $24.8M. Twelve months later TVGN was down 93%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.